158 related articles for article (PubMed ID: 25475140)
1. Inhibition of phospholipase D2 induces autophagy in colorectal cancer cells.
Hwang WC; Kim MK; Song JH; Choi KY; Min do S
Exp Mol Med; 2014 Dec; 46(12):e124. PubMed ID: 25475140
[TBL] [Abstract][Full Text] [Related]
2. Role of phospholipases D1 and 2 in astroglial proliferation: effects of specific inhibitors and genetic deletion.
Burkhardt U; Beyer S; Klein J
Eur J Pharmacol; 2015 Aug; 761():398-404. PubMed ID: 25967349
[TBL] [Abstract][Full Text] [Related]
3. The C-terminal domain of PLD2 participates in degradation of protein kinase CKII β subunit in human colorectal carcinoma cells.
Lee YH; Uhm JS; Yoon SH; Kang JY; Kim EK; Kang BS; Min do S; Bae YS
BMB Rep; 2011 Sep; 44(9):572-7. PubMed ID: 21944249
[TBL] [Abstract][Full Text] [Related]
4. Autoregulation of phospholipase D activity is coupled to selective induction of phospholipase D1 expression to promote invasion of breast cancer cells.
Kang DW; Park MH; Lee YJ; Kim HS; Lindsley CW; Alex Brown H; Min do S
Int J Cancer; 2011 Feb; 128(4):805-16. PubMed ID: 20473892
[TBL] [Abstract][Full Text] [Related]
5. Phospholipase D-mediated autophagic regulation is a potential target for cancer therapy.
Jang YH; Choi KY; Min DS
Cell Death Differ; 2014 Apr; 21(4):533-46. PubMed ID: 24317201
[TBL] [Abstract][Full Text] [Related]
6. Pan-Bcl-2 inhibitor Obatoclax is a potent late stage autophagy inhibitor in colorectal cancer cells independent of canonical autophagy signaling.
Koehler BC; Jassowicz A; Scherr AL; Lorenz S; Radhakrishnan P; Kautz N; Elssner C; Weiss J; Jaeger D; Schneider M; Schulze-Bergkamen H
BMC Cancer; 2015 Nov; 15():919. PubMed ID: 26585594
[TBL] [Abstract][Full Text] [Related]
7. BIX-01294 induces autophagy-associated cell death via EHMT2/G9a dysfunction and intracellular reactive oxygen species production.
Kim Y; Kim YS; Kim DE; Lee JS; Song JH; Kim HG; Cho DH; Jeong SY; Jin DH; Jang SJ; Seol HS; Suh YA; Lee SJ; Kim CS; Koh JY; Hwang JJ
Autophagy; 2013 Dec; 9(12):2126-39. PubMed ID: 24322755
[TBL] [Abstract][Full Text] [Related]
8. Overexpression of phospholipase D suppresses taxotere-induced cell death in stomach cancer cells.
Cho JH; Hong SK; Kim EY; Park SY; Park CH; Kim JM; Kwon OJ; Kwon SJ; Lee KS; Han JS
Biochim Biophys Acta; 2008 May; 1783(5):912-23. PubMed ID: 18190795
[TBL] [Abstract][Full Text] [Related]
9. Phospholipase D2 induces stress fiber formation through mediating nucleotide exchange for RhoA.
Jeon H; Kwak D; Noh J; Lee MN; Lee CS; Suh PG; Ryu SH
Cell Signal; 2011 Aug; 23(8):1320-6. PubMed ID: 21440060
[TBL] [Abstract][Full Text] [Related]
10. Phospholipase D2 downregulation induces cellular senescence through a reactive oxygen species-p53-p21Cip1/WAF1 pathway.
Lee YH; Bae YS
FEBS Lett; 2014 Aug; 588(17):3251-8. PubMed ID: 25064843
[TBL] [Abstract][Full Text] [Related]
11. Expression of phospholipase D2 in human colorectal carcinoma.
Saito M; Iwadate M; Higashimoto M; Ono K; Takebayashi Y; Takenoshita S
Oncol Rep; 2007 Nov; 18(5):1329-34. PubMed ID: 17914593
[TBL] [Abstract][Full Text] [Related]
12. Phospholipase D2 mediates survival signaling through direct regulation of Akt in glioblastoma cells.
Bruntz RC; Taylor HE; Lindsley CW; Brown HA
J Biol Chem; 2014 Jan; 289(2):600-16. PubMed ID: 24257753
[TBL] [Abstract][Full Text] [Related]
13. Baicalein induces autophagic cell death through AMPK/ULK1 activation and downregulation of mTORC1 complex components in human cancer cells.
Aryal P; Kim K; Park PH; Ham S; Cho J; Song K
FEBS J; 2014 Oct; 281(20):4644-58. PubMed ID: 25132405
[TBL] [Abstract][Full Text] [Related]
14. Phospholipase D2 regulates endothelial permeability through cytoskeleton reorganization and occludin downregulation.
Zeiller C; Mebarek S; Jaafar R; Pirola L; Lagarde M; Prigent AF; Némoz G
Biochim Biophys Acta; 2009 Jul; 1793(7):1236-49. PubMed ID: 19371764
[TBL] [Abstract][Full Text] [Related]
15. Depolarization-induced differentiation of PC12 cells is mediated by phospholipase D2 through the transcription factor CREB pathway.
Banno Y; Nemoto S; Murakami M; Kimura M; Ueno Y; Ohguchi K; Hara A; Okano Y; Kitade Y; Onozuka M; Murate T; Nozawa Y
J Neurochem; 2008 Mar; 104(5):1372-86. PubMed ID: 18004999
[TBL] [Abstract][Full Text] [Related]
16. The phospholipase D pathway mediates the inflammatory response of the retinal pigment epithelium.
Mateos MV; Kamerbeek CB; Giusto NM; Salvador GA
Int J Biochem Cell Biol; 2014 Oct; 55():119-28. PubMed ID: 25172550
[TBL] [Abstract][Full Text] [Related]
17. Hippocalcin increases phospholipase D2 expression through extracellular signal-regulated kinase activation and lysophosphatidic acid potentiates the hippocalcin-induced phospholipase D2 expression.
Oh DY; Yon C; Oh KJ; Lee KS; Han JS
J Cell Biochem; 2006 Apr; 97(5):1052-65. PubMed ID: 16294323
[TBL] [Abstract][Full Text] [Related]
18. BRAF associated autophagy exploitation: BRAF and autophagy inhibitors synergise to efficiently overcome resistance of BRAF mutant colorectal cancer cells.
Goulielmaki M; Koustas E; Moysidou E; Vlassi M; Sasazuki T; Shirasawa S; Zografos G; Oikonomou E; Pintzas A
Oncotarget; 2016 Feb; 7(8):9188-221. PubMed ID: 26802026
[TBL] [Abstract][Full Text] [Related]
19. Design, synthesis, and biological evaluation of halogenated N-(2-(4-oxo-1-phenyl-1,3,8-triazaspiro[4.5]decan-8-yl)ethyl)benzamides: discovery of an isoform-selective small molecule phospholipase D2 inhibitor.
Lavieri RR; Scott SA; Selvy PE; Kim K; Jadhav S; Morrison RD; Daniels JS; Brown HA; Lindsley CW
J Med Chem; 2010 Sep; 53(18):6706-19. PubMed ID: 20735042
[TBL] [Abstract][Full Text] [Related]
20. Phospholipase D (PLD) drives cell invasion, tumor growth and metastasis in a human breast cancer xenograph model.
Henkels KM; Boivin GP; Dudley ES; Berberich SJ; Gomez-Cambronero J
Oncogene; 2013 Dec; 32(49):5551-62. PubMed ID: 23752189
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
